Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | CA4 | P22748 | 2/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
| ▸ | BMP1 | P13497 | 1/20 | 0.49 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22469193 | 0.88 | CNR2 (0.72) | CNR2ALDH1A1GAATP53MEN1 | |
| SCHEMBL6801648 | 0.84 | MMP1 (0.61) | CNR2ALDH1A1GAATP53MEN1 | |
| SCHEMBL8607609 | 0.83 | KEAP1 (0.64) | CNR2ALDH1A1GAACA12CA2 | |
| SCHEMBL6808058 | 0.83 | ALDH1A1 (0.53) | CNR2ALDH1A1GAATP53MEN1 | |
| SCHEMBL6804193 | 0.82 | CNR2 (0.85) | CNR2MEN1KMT2ACA12CA1 | |
| SCHEMBL8200276 | 0.82 | KEAP1 (0.62) | CNR2ALDH1A1GAACA12CA2 | |
| SCHEMBL7961836 | 0.80 | KEAP1 (0.68) | CNR2KEAP1NFE2L2TAS2R14 | |
| SCHEMBL6807719 | 0.80 | CNR2 (0.51) | CNR2ALDH1A1TP53MEN1KMT2A | |
| SCHEMBL6802936 | 0.80 | CNR2 (0.53) | CNR2TP53CA12CA1CA2 | |
| SCHEMBL8606028 | 0.79 | CA9 (0.60) | CNR2CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | PTPRM, PTPRS, PTPRE | CNR2 4684/4885ALDH1A1 622/4885GAA 152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.